Upcoming FDA decisions & trial readouts

How to read this tracker

Each row is one future event for one drug: either a regulatory step, such as an FDA decision, or a clinical readout, where a company reports trial results. The Next catalyst column shows the timing at the precision the company gave it. An exact date, usually a PDUFA target action date, gets a countdown. A window such as “H1 2027” is labelled as company guidance, because that is all anyone outside the company knows; here is why windows are vague and how they narrow.

Phase / type sorts by stage of development, from Phase 1 through to FDA decisions. Click a type label for a plain-English explainer of that kind of event. Status tells you how far to trust the row: Verified means a person read the linked filing, Reported means it came from a secondary source and is waiting for that check, and Needs check means something in the source is ambiguous and the row's note says what. Click any row to see the note and the exact filing date.

The Source link goes straight to the document that announced the date, usually an 8-K or 6-K filed with the SEC. If you would rather check a date yourself than take our word for it, this walkthrough shows how to find and read the filing. Options shows whether the stock has listed options, from the OCC's directory of listed products. The full method is on the methodology page.